Taysha Gene Therapies (TSHA) Return on Sales [ROS] (2023 - 2026)
Taysha Gene Therapies (TSHA) reported Return on Sales [ROS] of -2792.32% for Q2 2026, down 1445.24 percentage points from -1347.08% a year earlier and down 1017.96 percentage points from the prior quarter.
Powered by 
Analysis
Taysha Gene Therapies (TSHA) Return on Sales [ROS] (2023 - 2026) Analysis & Trends
For FY2025, Taysha Gene Therapies posted Return on Sales [ROS] of -1130.65%, down 33.09 percentage points from FY2024.
- Return on Sales [ROS] has a three-year change of +5362.04 percentage points (FY2022 to FY2025).
- By year, Return on Sales [ROS] came in at -1097.55% in FY2024 (-628.72 pp), -468.83% in FY2023 (+6023.86 pp) and -6492.69% in FY2022.
- The Q2 2026 figure ranks as the lowest quarterly Return on Sales [ROS] in data going back to Q1 2023.
- Year over year, Return on Sales [ROS] gained in two of the last eight quarters, with an average year-over-year change of -409.92 percentage points.
- The high point for year-over-year Return on Sales [ROS] in five years was Q2 2025 (a gain of 568.30 percentage points); the low point was Q2 2026 (a drop of 1445.24 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -1774.37% (Q1 2026), -515.95% (Q4 2025) and -1618.54% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Taysha Gene Therapies | 1.51 Bn | 1.51 Bn | - | -2,792.32% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,792.32% |
| Mar 31, 2026 | -1,774.37% |
| Dec 31, 2025 | -515.95% |
| Sep 30, 2025 | -1,618.54% |
| Jun 30, 2025 | -1,347.08% |
| Mar 31, 2025 | -930.54% |
| Dec 31, 2024 | -985.76% |
| Sep 30, 2024 | -1,448.43% |
| Jun 30, 2024 | -1,915.38% |
| Mar 31, 2024 | -713.28% |
| Dec 31, 2023 | -450.78% |
| Sep 30, 2023 | -342.39% |
| Jun 30, 2023 | -976.37% |
| Mar 31, 2023 | -351.87% |
API Access
Taysha Gene Therapies Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=TSHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "TSHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=TSHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();